Pathobiology Awards
Explore details about the focus, goals, methods, and findings of individual RECOVER pathobiology studies.
66 Results
66 Results
ROA2024Adult
Evaluation of High-Throughput Measurements of Persistent SARS-CoV-2 in the Occurrence of Various PASC Phenotypes
Michael Peluso, University of California, San Francisco
ROA2024Tissue Pathology
Identification and Characterization of Viral Reservoirs in Patients with Post-Acute Sequelae of SARS-CoV-2 Infection
James Stone, Massachusetts General Hospital
ROA2024Adult
IgA Autoimmunity and Thrombosis among PASC Patients with Persistent Respiratory Symptoms
Ana Rodriguez Fernandez, New York University Grossman Long Island School of Medicine
ROA2024AdultPediatric
Integrating Age, Obesity, Inflammation, Metabolism, and Tissue Injury to Understand Postacute Sequelae of SARS-CoV-2 Infection
Senta Georgia, Children's Hospital Los Angeles
ROA2024Adult
Investigations of Increased Cardiovascular Risk and Coagulation in Survivors of COVID-19 including those with PASC: Role of Oxidative Lipids and Glucose Metabolism
Grace McComsey, Case Western Reserve University
ROA2024AdultTissue Pathology
Leveraging RECOVER Infrastructure to Identify the Signatures and Pharmacological Treatments for PASC Respiratory Conditions
Kelan Tantisira, University of California, San Diego
ROA2024Pediatric
Neuro-threat Circuity in POTS and PASC: Distinct or More of the Same?
Patricia Kinser, Virginia Commonwealth University